Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the debt to assets ratio high or low?
The debt to assets ratio of 2.73% is 47% above its 5-year average of 1.86%, near the high end of its 5-year range (1.11%–3.13%).
As of the fiscal period ended Tuesday, June 30, 2026. 3.32% below its 12-month average of 2.82%.
Reported quarterly debt to assets ratio; no daily interpolation. Q2 FY2026 (2026-06-30): 2.73%.
DEBT TO ASSETS RATIO
2.73%
DEBT TO ASSETS RATIO AVG TTM
2.82%
DEBT TO ASSETS RATIO AVG 3Y
2.21%
DEBT TO ASSETS RATIO AVG 5Y
1.86%
DEBT TO ASSETS RATIO AVG 10Y
1.21%
DEBT TO ASSETS RATIO AVG 15Y
N/A
DEBT TO ASSETS RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
-3.32%
CURRENT VS 3Y AVG
+23.44%
CURRENT VS 5Y AVG
+46.65%
CURRENT VS 10Y AVG
+125.08%
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
0.10%
median of 664 covered companies
CURRENT VS SECTOR MEDIAN
+2627.38%
vs the sector median at left
AC Immune S.A.
Market Cap
$262.07M
Debt to Assets Ratio
2.73%
TTM Avg
2.82%
3Y Avg
2.21%
5Y Avg
1.86%
Market Cap
$261.98M
Debt to Assets Ratio
0.00%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$260.64M
Debt to Assets Ratio
0.03%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$266.50M
Debt to Assets Ratio
0.01%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$266.79M
Debt to Assets Ratio
0.03%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$257.13M
Debt to Assets Ratio
0.12%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$267.31M
Debt to Assets Ratio
0.00%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$256.01M
Debt to Assets Ratio
0.13%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$269.87M
Debt to Assets Ratio
0.10%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
| NAME | MARKET CAP | DEBT TO ASSETS RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| AC Immune S.A. (ACIU) | $262.07M | 2.73% | 2.82% | 2.21% | 1.86% |
| Inhibikase Therapeutics, Inc. (IKT)vs › | $261.98M | 0.00% | N/A | N/A | N/A |
| Lexeo Therapeutics, Inc. Common Stock (LXEO)vs › | $260.64M | 0.03% | N/A | N/A | N/A |
| Eupraxia Pharmaceuticals Inc. (EPRX)vs › | $266.50M | 0.01% | N/A | N/A | N/A |
| OraSure Technologies, Inc. (OSUR)vs › | $266.79M | 0.03% | N/A | N/A | N/A |
| Century Therapeutics, Inc. (IPSC)vs › | $257.13M | 0.12% | N/A | N/A | N/A |
| Palisade Bio, Inc. (PALI)vs › | $267.31M | 0.00% | N/A | N/A | N/A |
| Anika Therapeutics, Inc. (ANIK)vs › | $256.01M | 0.13% | N/A | N/A | N/A |
| EyePoint Pharmaceuticals, Inc. (EYPT)vs › | $269.87M | 0.10% | N/A | N/A | N/A |
| Nautilus Biotechnolgy, Inc. (NAUT)vs › | $249.42M | 0.17% | N/A | N/A | N/A |
Debt/Assets
2.7%
Debt/Equity
0.12
Current Ratio
0.93
Interest Coverage
-360.5x
Formula: Debt/Assets = Total Debt / Total Assets × 100
Debt/Assets vs Debt/Equity:
Industry context matters: Capital-intensive industries (utilities, real estate) typically have higher Debt/Assets ratios than tech companies.
Debt/Assets ratio shows what percentage of a company's assets are financed by debt. Compare the current value with the historical chart and peer group to understand leverage over time.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | DEBT TO ASSETS RATIO |
|---|---|
| 2026-06-30 | 2.73% |
| 2026-03-31 | 3.13% |
| 2025-12-31 | 2.94% |
| 2025-09-30 | 2.72% |
| 2025-06-30 | 2.59% |
| 2025-03-31 | 2.45% |
| 2024-12-31 | 2.35% |
| 2024-09-30 | 1.26% |
| 2024-06-30 | 1.36% |
| 2024-03-31 | 1.99% |
| 2023-12-31 | 1.91% |
| 2023-09-30 | 1.67% |
| 2023-06-30 | 1.62% |
| 2023-03-31 | 1.58% |
| 2022-12-31 | 1.51% |
| 2022-09-30 | 1.21% |
| 2022-06-30 | 1.21% |
| 2022-03-31 | 1.18% |
| 2021-12-31 | 1.11% |
| 2021-09-30 | 1.26% |
| 2021-06-30 | 1.28% |
| 2021-03-31 | 0.94% |
| 2020-12-31 | 0.93% |
| 2020-09-30 | 0.87% |
| 2020-06-30 | 0.86% |
| 2020-03-31 | 0.86% |
| 2019-12-31 | 0.97% |
| 2019-09-30 | 0.80% |
| 2019-06-30 | 0.87% |
| 2019-03-31 | 15.80% |
| 2018-12-31 | 0.26% |
| 2018-09-30 | 0.28% |
| 2018-06-30 | 0.49% |
| 2018-03-31 | 0.36% |
| 2017-12-31 | 0.30% |
| 2017-09-30 | 0.31% |
| 2017-06-30 | 0.29% |
| 2017-03-31 | 0.00% |
| 2016-12-31 | 0.00% |
| 2016-09-30 | 0.00% |
| 2016-06-30 | 0.00% |
| 2016-03-31 | 0.00% |
| 2015-12-31 | 0.00% |
| 2015-09-30 | 0.00% |
| 2015-06-30 | 0.00% |
| 2014-12-31 | 0.00% |
